Dirk Foell

22.0k total citations · 5 hit papers
205 papers, 12.3k citations indexed

About

Dirk Foell is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Dirk Foell has authored 205 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 88 papers in Immunology and 76 papers in Hematology. Recurrent topics in Dirk Foell's work include Autoimmune and Inflammatory Disorders Research (72 papers), Inflammasome and immune disorders (54 papers) and S100 Proteins and Annexins (46 papers). Dirk Foell is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (72 papers), Inflammasome and immune disorders (54 papers) and S100 Proteins and Annexins (46 papers). Dirk Foell collaborates with scholars based in Germany, United States and Netherlands. Dirk Foell's co-authors include Johannes Roth, Thomas Vogl, Helmut Wittkowski, Clemens Sorg, Michael Frosch, Cord Sunderkötter, Dirk Holzinger, Jan Ehrchen, Wolfgang Nacken and Christoph Kessel and has published in prestigious journals such as The Lancet, JAMA and Nature Medicine.

In The Last Decade

Dirk Foell

198 papers receiving 12.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

2007 1.1k citations Thomas Vogl, Marieke A. D. van Zoelen et al. profile →
S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

2006 681 citations Dirk Foell, Helmut Wittkowski et al. profile →
The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

2009 662 citations Jan Ehrchen, Cord Sunderkötter et al. profile →
Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells

2008 566 citations Dirk Foell, Hudson H. Freeze et al. The Journal of Immunology profile →
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

2018 261 citations Dirk Holzinger, Dirk Foell et al. profile →

Peers

Countries citing papers authored by Dirk Foell

Since Specialization

Citations

This map shows the geographic impact of Dirk Foell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Foell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Foell more than expected).

Fields of papers citing papers by Dirk Foell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Foell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Foell. The network helps show where Dirk Foell may publish in the future.

Co-authorship network of co-authors of Dirk Foell

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Foell. A scholar is included among the top collaborators of Dirk Foell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Foell. Dirk Foell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LBA0008 EFFECTIVENESS OF CANAKINUMAB FOR FIRST LINE STEROID FREE TREATMENT IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS 2024 ·Annals of the Rheumatic Diseases ·(unknown), Ariane Klein, Kirsten Minden, Tilmann Kallinich, (unknown), (unknown), (unknown), Dirk Foell	1
2	Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort 2024 ·Pediatric Rheumatology ·(unknown), (unknown), Jens Klotsche, Ina Liedmann, Martina Niewerth, Anton Hospach, (unknown), (unknown), Frank Weller‐Heinemann, Ivan Foeldvari, Tilmann Kallinich, Johannes‐Peter Haas, Daniel Windschall, Frank Dressler, Dirk Foell, Jasmin Kuemmerle‐Deschner, Kirsten Minden	0
3	Dysregulation of miRNA-30e-3p targeting IL-1β in an international cohort of systemic autoinflammatory disease patients 2023 ·Journal of Molecular Medicine ·(unknown), Yeliz Z. Akkaya‐Ulum, Ezgi Deniz Batu, Federica Penco, Helmut Wittkowski, (unknown), Mariëlle van Gijn, Dirk Foell, Marco Gattorno, Seza Özen, Banu Balcı‐Peynircioğlu	7
4	Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients—analysis of the BiKeR registry 2023 ·Rheumatology International ·(unknown), Ariane Klein, Jasmin Kuemmerle‐Deschner, Frank Dressler, (unknown), (unknown), Maria Faßhauer, Toni Hospach, Markus Hufnagel, Dirk Foell, Gerd Horneff	4
5	Treatment of systemic juvenile idiopathic arthritis 2023 ·Nature Reviews Rheumatology ·Claas Hinze, Dirk Foell, Christoph Kessel	19
6	Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial 2022 ·Annals of the Rheumatic Diseases ·Joachim Gerß, (unknown), Ariane Klein, Gerd Horneff, (unknown), Christoph Kessel, Dirk Holzinger, Valda Staņēviča, Joost F. Swart, David A. Cabral, Hermine I. Brunner, Dirk Foell	19
7	Application of systems biology-based in silico tools to optimize treatment strategy identification in Still’s disease 2021 ·Arthritis Research & Therapy ·(unknown), Mireia Coma, Christoph Kessel, Serge Smeets, Dirk Foell, Anna Aldea	24
8	Increased Prevalence of NLRP3 Q703K Variant Among Patients With Autoinflammatory Diseases: An International Multicentric Study 2020 ·Frontiers in Immunology ·Katerina Theodoropoulou, Helmut Wittkowski, Nathalie Busso, Annette von Scheven-Gête, Isabelle Moix, Federica Vanoni, (unknown), Gerd Horneff, Johannes‐Peter Haas, Nadine Fischer, (unknown), Rainer Berendes, Georg Heubner, Annette Jansson, Elke Lainka, Annette Leimgruber, Michael A. Morris, Dirk Foell, Michaël Hofer	16
9	Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis 2019 ·Arthritis & Rheumatology ·(unknown), Kimberly Morishita, Paul Dancey, Paul Moorehead, Britt I. Drögemöller, Xiaohua Han, Jinko Graham, Robert E. W. Hancock, Dirk Foell, Susanne M. Benseler, (unknown), Rae S. M. Yeung, Susan Shenoi, Marek Böhm, Alan Rosenberg, Colin J.D. Ross, David A. Cabral, Kelly L. Brown, (unknown)	38
10	Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis 2019 ·Annals of the Rheumatic Diseases ·Faekah Gohar, Angela McArdle, (unknown), (unknown), Belinda Hernández, Christoph Kessel, (unknown), Miha Lavrič, Dirk Holzinger, (unknown), Elke Lainka, Sebastiaan J. Vastert, Sytze de Roock, Oliver FitzGerald, Stephen R. Pennington, Dirk Foell	17
11	Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance 2019 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Dirk Holzinger, Toni Weinhage, Claas Hinze, Helmut Wittkowski, Peter Pickkers, Sabrin Albeituni, Katherine Verbist, Kim E. Nichols, Grant S. Schulert, Alexei A. Grom, Dirk Foell, Christoph Kessel	41
12	An amino acid motif in HLA-DRβ1 distinguishes patients with uveitis in juvenile idiopathic arthritis 2018 ·Arthritis & Rheumatism ·(unknown), Marco W. Schilham, Sylvia Kamphuis, P Müller, Arnd Heiligenhaus, Dirk Foell, Kirsten Minden, Roel A. Ophoff, Timothy R. D. J. Radstake, Anneke I. den Hollander, (unknown), Sanne Hiddingh, Nicoline E. Schalij‐Delfos, Joke H. de Boer, Sara L. Pulit, Jonas J. W. Kuiper	1
13	Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria 2018 ·Pediatric Rheumatology ·Claas Hinze, Prasad T. Oommen, Frank Dressler, Andreas Urban, Frank Weller‐Heinemann, Fabian Speth, Elke Lainka, Jürgen Brunner, Heike Fesq, Dirk Foell, Wolfgang Müller‐Felber, Ulrich Neudorf, Christoph Rietschel, Tobias Schwarz, Ulrike Schara, Johannes‐Peter Haas	29
14	Proinflammatory S100A12 Can Activate Human Monocytes via Toll-like Receptor 4 2013 ·American Journal of Respiratory and Critical Care Medicine ·Dirk Foell, Helmut Wittkowski, Christoph Kessel, (unknown), Toni Weinhage, Georg Varga, Thomas Vogl, Timo Wirth, Dorothee Viemann, Per Björk, Marieke A. D. van Zoelen, Faekah Gohar, Geetha Srikrishna, Matthias Kraft, Johannes Roth	140
15	Author's response 2010 ·Gut ·Dirk Foell	1
16	Keratinocytes Determine Th1 Immunity during Early Experimental Leishmaniasis 2010 ·PLoS Pathogens ·Jan Ehrchen, Kirsten Roebrock, Dirk Foell, Nadine Nippe, Esther von Stebut, Johannes M. Weiss, (unknown), Dorothee Viemann, Georg Varga, Carsten Müller‐Tidow, Hans‐Joachim Schuberth, Johannes Roth, Cord Sunderkötter	51
17	Expression and Role of Myeloid-related Protein-14 in Clinical and Experimental Sepsis 2009 ·American Journal of Respiratory and Critical Care Medicine ·Marieke A. D. van Zoelen, Thomas Vogl, Dirk Foell, Suzanne Q. van Veen, J. W. Olivier van Till, Sandrine Florquin, Michael W.T. Tanck, Xavier Wittebole, Pierre‐François Laterre, Marja A. Boermeester, Johannes Roth, Tom van der Poll	112
18	S100A12-expression is upregulated by TNF and may serve as a marker for the success of anti-TNF therapy 2005 ·Ghent University Academic Bibliography (Ghent University) ·Helmut Wittkowski, A-K Ulfgren, Leen De Rycke, Filip De Keyser, Lars Klareskog, Jürgen Röth, Dirk Foell	1
19	Carboxylated Glycans Mediate Colitis through Activation of NF-κB 2005 ·The Journal of Immunology ·Geetha Srikrishna, Olga Turovskaya, (unknown), (unknown), Dirk Foell, Simon Murch, Mitchell Kronenberg, Hudson H. Freeze	38
20	Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease 2003 ·Gut ·Dirk Foell, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	241

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact